Key result
Extracellular vesicles drive key inflammatory mechanisms across atherosclerosis, ischemic heart disease, and heart failure.
Why the study?
Extracellular vesicles are implicated in innate and adaptive immune responses that underlie most cardiovascular disorders, prompting a review of their mechanistic role at the intersection of inflammation and cardiovascular disease.
Extracellular vesicles are emerging as key mediators of inflammation in cardiovascular disease, offering potential as diagnostic biomarkers and therapeutic targets.
Answers are grounded in this paper and cite their sources.
Supports investigation of extracellular vesicle biomarkers in inflammatory CVD; leaves open therapeutic targeting pending prospective validation.
Cardiovascular disease is a leading cause of death worldwide. The underlying mechanisms of most cardiovascular disorders involve innate and adaptive immune responses, and extracellular vesicles are implicated in both. In this review, we describe the mechanistic role of extracellular vesicles at the intersection of inflammatory processes and cardiovascular disease. Our discussion focuses on atherosclerosis, myocardial ischemia and ischemic heart disease, heart failure, aortic aneurysms, and valvular pathology.
No takes yet. Share an insight, caveat, or question.
Akhmerov et al. (2022) conducted a review in Cardiovascular disease. Extracellular vesicles was evaluated. Extracellular vesicles play a key mechanistic role at the intersection of inflammatory processes and cardiovascular diseases, including atherosclerosis, ischemic heart disease, and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: